# Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

> **NCT06813508** · — · RECRUITING · sponsor: **IRCCS Azienda Ospedaliero-Universitaria di Bologna** · enrollment: 1000 (estimated)

## Conditions studied

- Metabolic Dysfunction-Associated Steatotic Liver Disease
- Hepatocellular Carcinoma
- Metabolic Dysfunction-Associated Steatohepatitis
- Liver Transplant

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06813508
- **Lead sponsor:** IRCCS Azienda Ospedaliero-Universitaria di Bologna
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2043-11-20
- **Final completion:** 2044-11-20
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06813508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06813508, "Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT06813508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*